Cryo-cell International Share Price (NYSE: CCEL)

$4.72

▲

-0.03

(-0.63%)

Last updated on August 30, 2025 at 1:28 am IST

$₹

Check the interactive Cryo-cell International Stock chart to analyse performance

Cryo-cell International Inc Key Stats

Check Cryo-cell International key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$4.75
Open	$4.55
Market Capitalization	$37.9M
Today's Volume	$49.2K
Revenue TTM	$32.0M
EBITDA	$4.8M
Earnings Per Share (EPS)	$-0.02
Dividend Yield	13.68%
Profit Margin	-0.54%
Quarterly Earnings Growth YOY	-0.5%
Return On Equity TTM	129.2%

Stock Returns calculator for Cryo-cell International Stock including INR - Dollar returns

The Cryo-cell International stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Cryo-cell International investment value today

Current value as on today

₹76,368

Returns

₹23,632

(-23.63%)

Returns from Cryo-cell International Stock

₹28,916 (-28.92%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Cryo-cell International Stock

-27%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Cryo-cell International Stock from India on INDmoney has decreased by -27% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Cryo-cell International Inc

Name
Holdings %
Name
Holdings %
Hamilton Lane Advisors LLC
5.09%
SFI Advisors, LLC
2.05%
Vanguard Group Inc
1.61%
MASSMUTUAL TRUST CO FSB/ADV
1.38%
Topline Capital Management LLC
0.59%
Geode Capital Management, LLC
0.56%

Analyst Recommendation on Cryo-cell International Stock

Rating

Trend

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Cryo-cell International(by analysts ranked 0 to 5 stars)

Cryo-cell International Share Price Target

What analysts predicted

Upside of 80.08%

Target:

$8.50

Current:

$4.72

Cryo-cell International share price target is $8.50, a slight Upside of 80.08% compared to current price of $4.72 as per analysts' prediction.

Cryo-cell International Stock Insights

Price Movement
In the last 6 months, CCEL stock has moved down by -39.9%
Decreasing Revenue
Revenue is down for the last 4 quarters, 8.06M → 7.92M (in $), with an average decrease of 0.6% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -1.86M → 355.78K (in $), with an average increase of 389.3% per quarter
CCEL vs FMS (1 yr)
In the last 1 year, Fresenius Medical Care Ag has given 32.5% return, outperforming this stock by 55.9%
CCEL vs THC (3 yr)
In the last 3 years, Tenet Healthcare Corp. has given 50.6% return, outperforming this stock by 85.1%
Price to Sales
ForCCEL every $1 of sales, investors are willing to pay $1.2, whereas for Fresenius Medical Care Ag, the investors are paying $0.8 for every $1 of sales.

Cryo-cell International Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$31.8M	↑ 8.89%
Net Income	$2.3M	↓ 367.98%
Net Profit Margin	7.2%	↑ 10.13%

	FY20	Y/Y Change
Revenue	$31.1M	↓ 2.1%
Net Income	$3.6M	↑ 58.23%
Net Profit Margin	11.64%	↑ 4.44%

	FY21	Y/Y Change
Revenue	$28.9M	↓ 7.26%
Net Income	$2.1M	↓ 42.52%
Net Profit Margin	7.21%	↓ 4.43%

	FY22	Y/Y Change
Revenue	$30.3M	↑ 5.03%
Net Income	$2.8M	↑ 33.02%
Net Profit Margin	9.14%	↑ 1.93%

	FY23	Y/Y Change
Revenue	$31.3M	↑ 3.32%
Net Income	$-9.5M	↓ 443.57%
Net Profit Margin	-30.38%	↓ 39.52%

	FY24	Y/Y Change
Revenue	$32.0M	↑ 2.05%
Net Income	$402.1K	↓ 104.22%
Net Profit Margin	1.26%	↑ 31.64%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$7.9M	↓ 0.31%
Net Income	$556.2K	↓ 104.97%
Net Profit Margin	7.08%	↑ 149.14%

	Q2 FY24	Q/Q Change
Revenue	$8.0M	↑ 2.43%
Net Income	$655.8K	↑ 17.9%
Net Profit Margin	8.15%	↑ 1.07%

	Q3 FY24	Q/Q Change
Revenue	$8.1M	↑ 0.3%
Net Income	$1.1M	↑ 60.37%
Net Profit Margin	13.04%	↑ 4.89%

	Q4 FY24	Q/Q Change
Revenue	$8.0M	↓ 0.53%
Net Income	$-1.9M	↓ 277.01%
Net Profit Margin	-23.2%	↓ 36.24%

	Q1 FY25	Q/Q Change
Revenue	$8.0M	↓ 0.69%
Net Income	$282.9K	↓ 115.19%
Net Profit Margin	3.55%	↑ 26.75%

	Q2 FY25	Q/Q Change
Revenue	$7.9M	↓ 0.5%
Net Income	$355.8K	↑ 25.78%
Net Profit Margin	4.49%	↑ 0.94%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$21.8M	↑ 5.33%

	FY20	Y/Y Change
Profit	$21.5M	↓ 1.33%

	FY21	Y/Y Change
Profit	$19.9M	↓ 7.42%

	FY22	Y/Y Change
Profit	$21.5M	↑ 8.29%

	FY23	Y/Y Change
Profit	$22.9M	↑ 6.3%

	FY24	Y/Y Change
Profit	$24.0M	↑ 4.96%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$5.7M	↓ 1.89%

	Q2 FY24	Q/Q Change
Profit	$6.0M	↑ 5.73%

	Q3 FY24	Q/Q Change
Profit	$5.9M	↓ 1.28%

	Q4 FY24	Q/Q Change
Profit	$6.4M	↑ 7.52%

	Q1 FY25	Q/Q Change
Profit	$6.0M	↓ 6.31%

	Q2 FY25	Q/Q Change
Profit	$6.1M	↑ 1.47%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$6.3M	↑ 18.56%
Investing Cash Flow	$-690.7K	↓ 93.88%
Financing Cash Flow	$-5.1M	↓ 189.87%

	FY20	Y/Y Change
Operating Cash Flow	$8.5M	↑ 33.9%
Investing Cash Flow	$357.5K	↓ 151.76%
Financing Cash Flow	$-5.0M	↓ 2.49%

	FY21	Y/Y Change
Operating Cash Flow	$7.9M	↓ 6.38%
Investing Cash Flow	$-7.0M	↓ 2044.47%
Financing Cash Flow	$-3.1M	↓ 38.59%

	FY22	Y/Y Change
Operating Cash Flow	$8.6M	↑ 8.16%
Investing Cash Flow	$-15.3M	↑ 119.81%
Financing Cash Flow	$147.9K	↓ 104.81%

	FY23	Y/Y Change
Operating Cash Flow	$8.9M	↑ 4.05%
Investing Cash Flow	$-8.1M	↓ 46.7%
Financing Cash Flow	$-2.1M	↓ 1501.91%

	FY24	Y/Y Change
Operating Cash Flow	$6.0M	↓ 32.61%
Investing Cash Flow	$-4.9M	↓ 40.12%
Financing Cash Flow	$-979.1K	↓ 52.77%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-356.9K	↓ 110.67%
Investing Cash Flow	$-341.0K	↓ 82.79%
Financing Cash Flow	$539.0K	↓ 134.98%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$1.8M	↓ 596.96%
Investing Cash Flow	$-2.8M	↑ 707.68%
Financing Cash Flow	$1.2M	↑ 123.25%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$2.4M	↑ 37.43%
Investing Cash Flow	$-665.6K	↓ 75.84%
Financing Cash Flow	$-2.0M	↓ 269.84%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$2.2M	↓ 11.5%
Investing Cash Flow	$-1.1M	↑ 67.61%
Financing Cash Flow	$-677.8K	↓ 66.83%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$954.1K	↓ 55.77%
Investing Cash Flow	$-287.5K	↓ 74.23%
Financing Cash Flow	$-1.0M	↑ 48.18%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$707.0K	↓ 25.89%
Investing Cash Flow	$-1.5M	↑ 422.74%
Financing Cash Flow	$710.2K	↓ 170.7%

Cryo-cell International Technicals Summary

Sell

Neutral

Buy

Cryo-cell International is currently in a neutral trading position according to technical analysis indicators.

Cryo-cell International Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Cryo-cell International Inc	-4.23%	-29.32%	-28.46%	-32.24%	-59.05%
Fresenius Medical Care Ag	2.27%	9.13%	33.85%	52.16%	-38.9%
Hca Holdings, Inc.	13.07%	29.66%	1.97%	102.37%	200.76%
Encompass Health Corporation	12.13%	21.96%	30.5%	149.95%	85.63%
Universal Health Services Inc.	11.44%	3.32%	-23.19%	86.77%	64.27%
Tenet Healthcare Corp.	16.59%	47.97%	14.02%	226.96%	548.52%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Cryo-cell International Inc	490.98	NA	0.0	0.04	1.29	0.04	0.14	-1.93
Fresenius Medical Care Ag	19.34	19.34	0.42	1.96	0.06	0.03	0.03	45.23
Hca Holdings, Inc.	16.98	16.98	1.32	26.34	1.36	0.12	0.01	-18.61
Encompass Health Corporation	23.73	23.73	NA	5.28	0.25	0.09	0.01	22.6
Universal Health Services Inc.	9.57	9.57	1.87	20.44	0.19	0.08	0.0	110.47
Tenet Healthcare Corp.	11.59	11.59	0.85	15.81	0.3	0.08	NA	42.44

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Cryo-cell International Inc	Buy	$37.9M	-59.05%	490.98	-0.54%
Fresenius Medical Care Ag	Hold	$14.8B	-38.9%	19.34	3.36%
Hca Holdings, Inc.	Buy	$95.3B	200.76%	16.98	8.21%
Encompass Health Corporation	Buy	$12.4B	85.63%	23.73	9.22%
Universal Health Services Inc.	Hold	$11.6B	64.27%	9.57	7.66%
Tenet Healthcare Corp.	Buy	$16.3B	548.52%	11.59	7.18%

About Cryo-cell International Inc

Cryo-Cell International, Inc. engages in cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells, which are used in regenerative medicine to treat a range of conditions. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Organization	Cryo-cell International
Employees	82
CEO	Mr. Mark L. Portnoy
Industry	Services to the Health Industry

Key Management of Cryo-cell International Inc

Name	Title
Mr. David I. Portnoy	Chairman & Co-CEO
Mr. Mark L. Portnoy	Co-CEO & Director
Ms. Jill M. Taymans	CFO & VP of Finance
Mr. Oleg Mikulinsky	Chief Information Officer
Dr. Joanne Kurtzberg M.D.	Medical Director and Member of Medical & Scientific Advisory Board

Important FAQs about investing in CCEL Stock from India :

What is Cryo-cell International share price today?

Cryo-cell International share price today is $4.72 as on August 30, 2025 at 1:28 am IST at the close of the market. Cryo-cell International share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Cryo-cell International share?

Cryo-cell International share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Cryo-cell International stock price today i.e. August 30, 2025 at 1:28 am IST is closed at $4.72, lower by 49.95% versus the 52 week high.

How to invest in Cryo-cell International Stock (CCEL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cryo-cell International on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cryo-cell International Shares that will get you 0.3178 shares as per Cryo-cell International share price of $4.72 per share as on August 30, 2025 at 1:28 am IST.

What is the minimum amount required to buy Cryo-cell International Stock (CCEL) from India?

Indian investors can start investing in Cryo-cell International (CCEL) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Cryo-cell International stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Cryo-cell International share’s latest price of $4.72 as on August 30, 2025 at 1:28 am IST, you will get 2.1186 shares of Cryo-cell International. Learn more about fractional shares .

What are the returns that Cryo-cell International has given to Indian investors in the last 5 years?

Cryo-cell International stock has given -59.05% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?